Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury
CNS Neuroscience & Therapeutics · 2023-04 · 29 (4) · 1094-1108
DOI: 10.1111/cns.14085 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 10.01.2023. Verfasst von Shining Xiao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Spinal Cord Injuries, Flavones. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Background
A growing body of research shows that drug monomers from traditional Chinese herbal medicines have antineuroinflammatory and neuroprotective effects that can significantly improve the recovery of motor function after spinal cord injury (SCI). Here, we explore the role and molecular mechanisms of Alpinetin on activating microglia‐mediated neuroinflammation and neuronal apoptosis after SCI.
Methods
Stimulation of microglia with lipopolysaccharide (LPS) to simulate neuroinflammation models in vitro, the effect of Alpinetin on the release of pro‐inflammatory mediators in LPS‐induced microglia and its mechanism were detected. In addition, a co‐culture system of microglia and neuronal cells was constructed to assess the effect of Alpinetin on activating microglia‐mediated neuronal apoptosis. Finally, rat spinal cord injury models were used to study the effects on inflammation, neuronal apoptosis, axonal regeneration, and motor function recovery in Alpinetin.
Results
Alpinetin inhibits microglia‐mediated neuroinflammation and activity of the JAK2/STAT3 pathway. Alpinetin can also reverse activated microglia‐mediated reactive oxygen species (ROS) production and decrease of mitochondrial membrane potential (MMP) in PC12 neuronal cells. In addition, in vivo Alpinetin significantly inhibits the inflammatory response and neuronal apoptosis, improves axonal regeneration, and recovery of motor function.
Conclusion
Alpinetin can be used to treat neurodegenerative diseases and is a novel drug candidate for the treatment of microglia‐mediated neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, China.
- Institute of Spine and Spinal Cord, Nanchang University, Nanchang, China.
- Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Shining Xiao, Yu Zhang
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Xiao, S., Zhang, Y., Liu, Z., Li, A., Tong, W., Xiong, X., Nie, J., Zhong, N., Zhu, G., Liu, J., & Liu, Z. (2023). Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neuroscience & Therapeutics, 29(4), 1094-1108. https://doi.org/10.1111/cns.14085
Vancouver
Xiao S, Zhang Y, Liu Z, Li A, Tong W, Xiong X, et al. Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neuroscience & Therapeutics. 2023;29(4):1094-1108. doi:10.1111/cns.14085
BibTeX
@article{Xiao2023,
author = {Xiao, Shining and Zhang, Yu and Liu, Zihao and Li, Anan and Tong, Weilai and Xiong, Xu and Nie, Jiangbo and Zhong, Nanshan and Zhu, Guoqing and Liu, Jiaming and Liu, Zhili},
title = {Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
volume = {29},
number = {4},
pages = {1094--1108},
doi = {10.1111/cns.14085}
}
EUVIMED